Source: Drug Metabolism and Drug Interactions. Unidade: FCF
Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, INTERLEUCINA 1, POLIMORFISMO
ABNT
HIMELFARB, Silvia Tchernin et al. Tumor necrosis factor-'alpha' and interleukin-6 expression in leukocytes and their association with polymorphisms and bone markers in diabetic individuals treated with pioglitazone. Drug Metabolism and Drug Interactions, v. 26, n. 1, p. 37-40, 2011Tradução . . Disponível em: https://doi.org/10.1515/DMDI.2011.100. Acesso em: 16 ago. 2024.APA
Himelfarb, S. T., Silva, F. A., Arazi, S. S., Farjado, C. M., Garofalo, A., Bertolami, M. C., et al. (2011). Tumor necrosis factor-'alpha' and interleukin-6 expression in leukocytes and their association with polymorphisms and bone markers in diabetic individuals treated with pioglitazone. Drug Metabolism and Drug Interactions, 26( 1), 37-40. doi:10.1515/DMDI.2011.100NLM
Himelfarb ST, Silva FA, Arazi SS, Farjado CM, Garofalo A, Bertolami MC, Bertolami A, Faludi AA, Sampaio MF, Rezende AA de, Hirata RDC, Hirata MH. Tumor necrosis factor-'alpha' and interleukin-6 expression in leukocytes and their association with polymorphisms and bone markers in diabetic individuals treated with pioglitazone [Internet]. Drug Metabolism and Drug Interactions. 2011 ; 26( 1): 37-40.[citado 2024 ago. 16 ] Available from: https://doi.org/10.1515/DMDI.2011.100Vancouver
Himelfarb ST, Silva FA, Arazi SS, Farjado CM, Garofalo A, Bertolami MC, Bertolami A, Faludi AA, Sampaio MF, Rezende AA de, Hirata RDC, Hirata MH. Tumor necrosis factor-'alpha' and interleukin-6 expression in leukocytes and their association with polymorphisms and bone markers in diabetic individuals treated with pioglitazone [Internet]. Drug Metabolism and Drug Interactions. 2011 ; 26( 1): 37-40.[citado 2024 ago. 16 ] Available from: https://doi.org/10.1515/DMDI.2011.100